title: Screening with serum galactomannan might be associated with better outcome than symptom-triggered galactomannan testing in allogeneic HSCT recipients with invasive aspergillosis.
authors.affiliation: Division of Infectious Diseases, San Martino University Hospital and Department of Health Sciences, University of Genoa.
authors.forename: Malgorzata
authors.initials: M
authors.lastname: Mikulska
authors.forename: Anna Maria
authors.initials: AM
authors.lastname: Raiola
authors.forename: Alessio
authors.initials: A
authors.lastname: Signori
authors.forename: Elisa
authors.initials: E
authors.lastname: Furfaro
authors.forename: Valerio
authors.initials: V
authors.lastname: Del Bono
authors.forename: Andrea
authors.initials: A
authors.lastname: Bacigalupo
authors.forename: Claudio
authors.initials: C
authors.lastname: Viscoli
mesh_terms: D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000401:mortality*; D006801:Humans; D055744:Invasive Pulmonary Aspergillosis / Q000401:mortality*; D008297:Male; D008351:Mannans / Q000097:blood*
chemical_list: D008351:Mannans